BioCentury
ARTICLE | Company News

Senetek, Polish Academy of Sciences deal

December 22, 2008 8:00 AM UTC

The academy granted Senetek exclusive, worldwide rights to a technology that inhibits an undisclosed cancer target using RNA interference (RNAi). The academy is eligible for royalties. In 2006, Senete...